• Akebia Therapeutics (NASDAQ:AKBA) Receives "Buy" Rating from HC Wainwright

    来源: Buzz FX / 14 1月 2025 12:31:17   America/New_York


    Akebia Therapeutics (NASDAQ:AKBA) Receives "Buy" Rating from HC Wainwright Written by MarketBeat January 14, 2025 Share Link copied to clipboard. Akebia Therapeutics ( NASDAQ:AKBA - Get Free Report ) 's stock had its "buy" rating reissued b
    Read more...
分享